Table 1 Correlation between miR-198 expression and different clinicopathological features in gastric cancer patients
From: Decreased miR-198 expression and its prognostic significance in human gastric cancer
Low miR-198 expression | High miR-198 expression | p value | |
|---|---|---|---|
Age | |||
≥60 | 36 (48.0 %) | 39 (52.0 %) | |
<60 | 17 (54.8 %) | 14 (45.2 %) | 0.336 |
Gender | |||
Male | 28 (46.7 %) | 32 (53.3 %) | |
Female | 25 (54.3 %) | 21 (45.7 %) | 0.278 |
Differentiation | |||
Well-moderate | 14 (41.2 %) | 20 (58.8 %) | |
Poor | 39 (54.2 %) | 33 (45.8 %) | 0.149 |
Lauren type | |||
Intestinal | 29 (43.9 %) | 37 (56.1 %) | |
Diffuse and mixed | 24 (60.0 %) | 16 (40.0 %) | 0.08 |
Tumor size | |||
≥5 cm | 38 (60.3 %) | 25 (39.7 %) | |
<5 cm | 15 (34.9 %) | 28 (65.1 %) | 0.009 |
Invasion depth | |||
T1, T2 | 16 (34.8 %) | 30 (65.2 %) | |
T3, T4 | 37 (61.7 %) | 23 (38.3 %) | 0.005 |
TNM stage | |||
I/II | 13 (35.1 %) | 24 (64.9 %) | 0.02 |
III | 40 (58.0 %) | 29 (42.0 %) | |
Lymphatic metastasis | |||
Negative | 12 (35.3 %) | 22 (64.7 %) | 0.03 |
Positive | 41 (56.9 %) | 31 (43.1 %) | |